Muskuloskeletal Diseases

2

Review clinical trials related to Muskuloskeletal Diseases. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Virtual Reality-based Rehabilitation for Traumatic Hand and Wrist Injuries

This randomized controlled trial aims to evaluate the effectiveness of immersive virtual reality (VR)-based Action Observation Therapy (AOT) as an adjunct to conventional rehabilitation in patients with traumatic wrist and hand injuries. Participants will receive standard rehabilitation treatment, and the intervention group will additionally undergo a six-week VR program involving observation and execution of functional hand and wrist movements. Outcomes related to hand function, grip strength, pain, proprioception, disability, and psychological factors will be assessed to determine the potential benefits of incorporating VR into rehabilitation programs.

Participants needed: 40
Trial details
Age: 18-75Biological sex: AllType: InterventionalSponsor: University of MalagaUpdated: Jun 8, 2026Locations: 1
Eligibility criteria

Adults aged 18 years or older. [+4]

Previous injury affecting the same hand. [+5]

Status: Recruiting

The RheumSafer Study: Improving Medication Appropriateness in People With Rheumatic Conditions

The goal of this prospective observational quality improvement study is to determine if a physician tool, MedSafer, combined with educational brochures for patients, can help to reduce the use of 'potentially inappropriate medications' (PIMs) in adults aged 60 and over with rheumatic conditions and polypharmacy (taking 5 or more regular medications). Researchers will follow participants during usual rheumatic disease care. They will compare the rate of PIM deprescribing (stopping medications or reducing the dose) before and after the introduction of the following interventions: * MedSafer reports provided to treating physicians * EMPOWER consumer brochures provided to participants Participants will complete 4 study visits over 18-20 months during which researchers will collect information on medication changes, serious adverse events (emergency visits or hospitalizations), and quality of life.

Participants needed: 100
Trial details
Age: 60+Biological sex: AllType: ObservationalSponsor: McGill University Health Centre/Research Institute of the McGill University Health CentreUpdated: May 1, 2026Locations: 1
Eligibility criteria

Aged ≥60 [+3]

Unable to provide informed consent [+1]